Elixinol Global Stock Today
| ELLXF Stock | USD 0.01 0.00 0.00% |
PerformanceOK
| Odds Of DistressLow
|
Elixinol Global is trading at 0.012 as of the 19th of March 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.012. Elixinol Global has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. The company has 316.27 M outstanding shares. More on Elixinol Global
Moving against Elixinol Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Elixinol Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Elixinol Global [ELLXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elixinol Global's market, we take the total number of its shares issued and multiply it by Elixinol Global's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elixinol Global classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 316.27 M outstanding shares.
Elixinol Global has accumulated about 6.93 M in cash with (14.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Elixinol Global Probability Of Bankruptcy
Ownership AllocationElixinol Global holds a total of 316.27 Million outstanding shares. Elixinol Global shows 15.67 percent of its outstanding shares held by insiders and 4.83 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Elixinol Ownership Details
Elixinol Global Risk Profiles
| Mean Deviation | 16.81 | |||
| Semi Deviation | 15.97 | |||
| Standard Deviation | 28.52 | |||
| Variance | 813.17 |
Elixinol Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elixinol Global without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Elixinol Global Corporate Management
| Kim BradleyWare | Joint Company Secretary | Profile | |
| Glen Zurcher | Account Department | Profile | |
| FCPA BEC | Interim Officer | Profile | |
| Teresa Cleary | G Sec | Profile | |
| Rob Hasselman | Pres Americas | Profile | |
| Josephine Lorenz | Global Controller | Profile | |
| Beata Silber | Global Innovation | Profile |
Other Information on Investing in Elixinol Pink Sheet
Elixinol Global financial ratios help investors to determine whether Elixinol Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Global security.